US large-cap equities likely have more downside, because consumer staples leading alongside small-cap biotech signals a reason to be wary. It is rare for both to lead at once, with small-cap biotech up 24.44% this year and 82.86% over the past year. July has historically been the S&P 500's best month since 1928, averaging about 1.7% and rising roughly 60% of the time, but seasonality is not a reliable guide here. x.com x.com x.comÂ